Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compounds.
about
Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol HexakisphosphateSoluble epoxide hydrolase deficiency inhibits dextran sulfate sodium-induced colitis and carcinogenesis in miceStool phospholipid signature is altered by diet and tumorsDisease Severity and Immune Activity Relate to Distinct Interkingdom Gut Microbiome States in Ethnically Distinct Ulcerative Colitis PatientsA Randomized Pilot Study of Inositol in Association with Betaine and Boswellia in the Management of Mastalgia and Benign Breast Lump in Premenopausal Women.The chemopreventive agent myoinositol inhibits Akt and extracellular signal-regulated kinase in bronchial lesions from heavy smokers.Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.The Effects of Myo-Inositol and B and D Vitamin Supplementation in the db/+ Mouse Model of Gestational Diabetes MellitusMolecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications.Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction.Myo-inositol reduces β-catenin activation in colitis.Stereomicroscopic features of colitis-associated tumors in mice: Evaluation of pit pattern.Differential influence of inositol hexaphosphate on the expression of genes encoding TGF-β isoforms and their receptors in intestinal epithelial cells stimulated with proinflammatory agents.Scientific Opinion on the safety and efficacy of inositol as a feed additive for fish, dogs and catsRole of different inflammatory and tumor biomarkers in the development of ulcerative colitis-associated carcinogenesis.Ferric citrate and ferric EDTA but not ferrous sulfate drive amphiregulin-mediated activation of the MAP kinase ERK in gut epithelial cancer cells.
P2860
Q28078208-70269CAD-3CCB-416A-8694-05C92059F3ECQ28389024-87001DD1-A012-4B88-A020-92015F45FB6CQ34627630-9A8B7A81-EC56-491A-A509-D35BC974CA33Q36105520-96B50D28-5800-472C-BE85-397FDFC38A26Q36822991-2030275C-D515-4D89-992A-53CF2CCDCF13Q37023660-13101B15-1E0E-4AD0-B044-0DD98D841B8FQ37148781-5F137F3C-537B-4E50-A112-E701D7EFF0EEQ37673227-97F7E942-6C51-4639-961F-CA52149CD0DBQ37851008-FFF97AE9-5424-4A60-8112-FB78659C94FFQ38728458-C696452D-4BE1-4299-8128-E69ACE5C2719Q41191056-499BA490-3F93-4AB1-8F6F-2AE213ECC22CQ41615354-C93279F3-10C0-4CA3-928F-A5BDC69A6E76Q41871173-79D233E3-91A3-4E2C-80DB-0A39CE15C9B6Q47154490-1818DB0A-8BE6-4907-8636-88ED6DD411F2Q53296152-AD38BC6B-CE8A-4EBA-80F5-B5C1D5B05993Q54114892-7F2379EC-DA3D-481F-ADC4-CEB6A4E8790E
P2860
Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compounds.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Inhibition of chronic ulcerati ...... in mice by inositol compounds.
@en
Inhibition of chronic ulcerati ...... in mice by inositol compounds.
@nl
type
label
Inhibition of chronic ulcerati ...... in mice by inositol compounds.
@en
Inhibition of chronic ulcerati ...... in mice by inositol compounds.
@nl
prefLabel
Inhibition of chronic ulcerati ...... in mice by inositol compounds.
@en
Inhibition of chronic ulcerati ...... in mice by inositol compounds.
@nl
P2093
P356
P1433
P1476
Inhibition of chronic ulcerati ...... in mice by inositol compounds.
@en
P2093
Allison L Yang
Darren N Seril
Guang-Yu Yang
P304
P356
10.1093/CARCIN/BGL154
P407
P577
2006-09-14T00:00:00Z